Chr. Hansen Loses Appeal Over Import Ban on Formula Supply

Chr. Hansen Holding’s Jennewein, a supplier for Abbott’s Similac baby formula, lost its appeals court bid to overturn an import ban on some of its human milk oligosaccharides.

• A U.S. International Trade Commission “did not err” in its decision that two Jennewein strains infringed a patent owned by Massachusetts-based Glycosyn, the U.S. Court of Appeals for the Federal Circuit ruled
• Glycosyn, which partners with BASF for some HMO products, had claimed HMOs made by Germany’s Jennewein infringed a patent for a way to process large quantities of HMO
• The commission cleared a newer alternative strain made by Jennewein
• NOTE: ...